Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Polygon’s POL eyes rally ahead of Heimdall v2 mainnet launch on July 10

Polygon’s POL eyes rally ahead of Heimdall v2 mainnet launch on July 10

Crypto.NewsCrypto.News2025/07/08 16:00
By:By Leon OkwatchEdited by Dorian Batycka

Polygon’s POL token is seeing renewed momentum just a day before the Heimdall v2 mainnet upgrade, set for July 10. 

At press time, Polygon ( POL ) is trading at $0.2001, up 7% in the past 24 hours and 11% over the past week. Trading volume has jumped 71.4% to $92 million, with derivatives volume up 67.87% to $83.75 million, as per Coinglass data . Open interest has also climbed 10.98%, now standing at $98.7 million. These figures point to increased activity in both the spot and derivatives network.

The upcoming upgrade marks a significant step in Polygon’s roadmap.  Since Polygon proof-of-stake launched in 2020, Heimdall v2 has been “the most technically complex hard fork,” according to co-founder Sandeep Nailwal. It updates the consensus layer from Tendermint and Cosmos-SDK v0.37 to CometBFT and Cosmos-SDK v0.50.

Shipping Announcement! 🚢

We’ve been on a shipping spree—and next up is Polygon PoS’s consensus layer, Heimdall v2, landing 10 July 2025.

‼️ This is the most technically complex hard-fork Polygon PoS has seen since it's launch in 2020 ‼️

What’s changing?
1. Heimdall sheds all…

— Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) July 8, 2025

Heimdall v2 also removes legacy code from 2018–2019, cutting technical debt and making the network easier to maintain. The new CometBFT consensus layer improves security, stability, and traceability, key features for applications in regulated sectors.

The upgrade supports Polygon’s effort to scale PoS throughput to 1,000 transactions per second in July, with an eventual target of over 5,000 TPS by October via AggLayer .

The mainnet upgrade is scheduled to take place between 2:00 PM and 5:00 PM UTC at block height 24,404,500. For post-fork compatibility, node operators have been instructed to switch to Heimdall v1.2.5 or fallback to version 1.2.4. Finality may lag by up to 3 hours during the migration, so dApps are encouraged to temporarily raise confirmation thresholds.

The update was successfully deployed on the Amoy testnet on June 24, giving the team confidence that the transition would proceed smoothly. Two significant improvements that were tested include PIP-62 and PIP-44, which are focused on dependency handling and genesis state import.

On the daily chart, POL is showing early signs of a breakout. The token has surpassed both the 20-day exponential moving average at $0.1686 and the 20-day simple moving average at $0.1823. The Bollinger Bands are starting to widen, suggesting increased volatility ahead. The intraday break of the upper band, which is at $0.1960, indicates upward momentum.

Polygon’s POL eyes rally ahead of Heimdall v2 mainnet launch on July 10 image 0 POL price analysis. Credit: crypto.news

At 56.78, the relative strength index is getting close to overbought territory but still has room to rise further. If bulls hold above the $0.196 resistance-turned-support, POL might retest the $0.22–$0.24 range. On the downside, the price might drop back to the lower Bollinger Band, which is at $0.168, if $0.19 is not held. 

Price action may still depend on network stability and the successful rollout on July 10th, even though technical indicators suggest a bullish outlook.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.

智通财经•2026/10/19 11:37
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"

Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.

智通财经•2026/10/19 11:18

Roadster is just an appetizer? Renowned investor predicts: SpaceX (SPCX.US) may announce the acquisition of Tesla (TSLA.US) within weeks at $420 per share

Gary Black, Managing Director of the Future Fund, recently tweeted a prediction that SpaceX may announce an all-stock acquisition of Tesla within weeks and view the launch of the flying edition Roadster as an opportunity to integrate Elon Musk's companies.

智通财经•2026/10/19 11:13